
NORMAN – Attorney General Mike Hunter announced Tuesday the terms of the $85 million settlement agreement with Israeli-based Teva Pharmaceuticals that was negotiated last month.
In addition to the funds going to the state to be used to abate the opioid epidemic, Teva will not employ or contract with sales representatives to promote opioids in the state; the company will not use speakers, key opinion leaders or speaking events to promote opioids; and the company will not provide direct or indirect financial support for branded or unbranded information promoting opioids, such as brochures, newsletters, books and guides.
Continue reading











